Financial intelligence for Asia's healthcare markets
Remember me:

News articles    

Alcidion has launched Miya MEMRe, a mobile electronic medical record that enables clinicians to review their current activity and caseload, be notified of critical issues, and access comprehensive patient records.
Shanghai-based 111 Inc, an integrated online and offline healthcare platform, has announced it is establishing an integrated online and offline healthcare retail channel with HEC Group.
RMIT University in Melbourne has partnered with the European Connected Health Alliance for the launch of a digital health ecosystem in Australia.
111 Inc, an integrated online and offline healthcare platform in China today announced a third quarter 2019 net loss of ¥123.9 million ($17.3 million).
Healthcare business Max India has received shareholder approval to merge its healthcare assets into Max Healthcare and demerge other residual businesses into Advaita, a wholly-owned subsidiary of Max India.
Singapore-based digital healthcare platform MyDoc has signed a deal with Hanoi-headquartered Baoviet Group Insurance to offer a cashless digitally integrated clinic service to its health insurance policyholders.
Interventional medical products provider Peijia Medical Co has raised $100 million in a Series C funding round led by its existing investor, venture capital firm Matrix Partners China.
English-Swedish multinational pharmaceutical and biopharmaceutical company AstraZeneca has announced three large-scale initiatives in China to advance global research and development for new medicines.
Global healthcare company MORE Health has agreed a collaboration with Japan’s Integrity Healthcare, giving international patients access to Integrity Healthcare’s physicians and services.
The Malaysia Healthcare Travel Council says the country’s hospital receipts will be in excess of 2 billion ringgit next year, fuelled by international healthcare tourists expected to number around two million.

Subscribe to our news RSS feed Get the RSS for HealthInvestor Asia




The IPO market in Hong Kong is hotting up again and it looks as though 2019 is going to be as busy with biotech company floats as last year was.



HealthInvestor Asia twitter feed


HealthInvestor UK